Abstract Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) may trigger the transcription factor AP-1 including c-Jun and c-fos. In this report, using a Tet-on LMP1 HNE2 cell line which is a dual-stable LMP1 integrated nasopharyngeal carcinoma (NPC) cell line and the expression of LMP1 in which could be regulated by the Tet-on system, we show that Jun B can efficiently form a new heterodimeric complex with the c-Jun protein under the regulation of LMP1, phosphorylation of c-Jun (ser 63, ser 73) and Jun B is involved in the process of the new heterodimeric formation. We also find that this heterodimeric form can bind to the AP-1 consensus sequence. Transfection studies suggest that JNK interaction protein (JIP) could inhibit the heterodimer formation of c-Jun and Jun B through blocking the AP-1 signaling pathway triggered by LMP1. The interaction and function between c-Jun protein and Jun B protein increase the repertoire of possible regulatory complexes by LMP1 that could play an important role in the regulation of transcription of specific cellular genes in the process of genesis of nasopharyngeal carcinoma.
Epstein Barr virus (EBV) encoded latent membrane protein 1 (LMP1) is considered the major oncogenic protein of EBV encoded proteins. LMP1 is an integral membrane protein composed of a short cytoplasmic N-terminus of 24 amino acids, 6 transmembrane domains of 162 amino acids and a cytoplasmic C-terminus of 200 amino acids. The carboxyl terminus of LMP1 comprises 2 functional domains: the membrane proximal c-terminal activation region-1 (CTA-R1) and the membrane distal CTAR2 (residues 351-386). CTAR2 activates an important signal transduction pathway, which is activating protein-l (AP-1) signaling pathway [1] . Many of the phenotypic changes are associated with LMP1's ability to activate AP-1. The AP-1 activation is a critical facet of LMP1 signaling shown by the findings that the AP-1 activation has caused abnormal cell proliferation [2] .
The AP-1 transcription factor consists of a large set of dimmer combinations formed between the Jun, Fos and ATF families of proteins. The Jun family, consisting of c-Jun, Jun B, and JunD, can form both heterodimers and homodimers among themselves, whereas the Fos family members (c-Fos, Fos B, Fra1, and Fra2) can only heterodimerize with Jun proteins. It is much cleared that Jun plays a vital role in the carcinogenesis. In line with the transcriptional activation in response to mitogenic signals, Jun proteins, alone or in cooperation with oncogenic proteins, can induce transformation, which is best characterized for c-Jun proteins.
In different environmental factors and different cell lines, c-Jun does not only promote cell proliferation, transformation and invasion, inhibit apoptosis [3, 4] , but also promote apoptosis [5] . Meanwhile, Jun B inhibits cell proliferation [6] , decreases invasion [7] and promotes cell differentiation [8, 9] , so it is always deemed to be the inhibitory factor of AP transcription factor [10] . However, some findings demonstrated that Jun B promotes the carcinogenesis [11] , inhibits cell differentiation [12] , and accelerates the process of carcinogenesis [13] . Further studies suggest that both c-Jun and Jun B antagonistically regulate cell proliferation, transformation, differentiation and gene expression in an AP-1-dependent manner [14 17] . Its mechanism may be that Jun B forms an inactive dimmer with c-Jun, which inhibits the role of c-Jun [18] . However, the recent findings demonstrate that c-Jun and Jun B cooperatively regulate the target genes in an AP-1 dependent manner, which promotes cell proliferation and differentiation abnormally [19, 20] .
In Tet-on-LMP1 HNE2 cell line [21] , in which the expression of LMP1 is induced by tetracycline (Doxycline, Dox) in a dose-dependent manner; LMP1 induced AP-1 in a time and dose course [22] . Using Atlas TM Apoptosis cDNA Expression Array, we found LMP1 induced both Jun B and c-Jun in a time-and dose-dependent manner in Tet-on LMP1 HNE2 cell line [23] . Meanwhile, JNK interacting protein 1 (JIP-1) inhibited the nuclear translocation of JNK, obviously blocked the AP-1 functional activation, and decreased the cell proliferation [24] . Further studies confirmed that LMP1 triggered a signaling cascade via its CTAR2 binding TRADD/TRAF2 signaling molecule, activated JNK and then up regulated AP1 activity including c-Jun and c-fos [22, 25] . In this study, we want to explore whether c-Jun interacts with Jun B under the regulation of LMP1. We found that LMP1 mediated the heterodimer form of c-Jun and Jun B; also the dimmer could bind to the DNA sequence. These findings suggest a new light on the role of the heterodimer of c-Jun and Jun B in the process of AP-1 signaling pathway triggered by LMP1.
Material and methods

Cell culture
The EBV-negative poorly differentiated NPC cell line HNE2 and the dual-stable LMP1 integrated NPC cell line Tet-on-LMP1-HNE2, in which the expression of LMP1 will be turned on by tetracycline (Doxycline, Dox), were established by Cancer Research Institute, Xiangya School of Medicine, Central South University [21] . Tet-on-LMP1-HNE2 cells were cultured in RPMI 1640 (GIBCO BRL) medium with 100 mg/L G418 and 50 mg/L hygromycin, supplemented with 10% fetal calf serum. To induce LMP1 expression, the cells were treated with Dox at the following doses: Dox 0, 0.006, 0.06, 0.6, 6.0 µg/mL. All cell lines grew at 37 under 5% CO 2 , and 95% air at 99% humidity.
Protein extraction
Whole-cell extracts were prepared essentially as described below [26] . After treating with various doses of Dox, the cells were washed with ice-cold PBS and lysed by 10 min incubation on ice with lysis buffer (10 mmol/L Tris·Cl pH 8.0, 1 mmol/L EDTA, 2% SDS, 5 mmol/L DTT, and 10 mmol/L PMSF, Proteinase inhibitors mix). The lysate was centrifuged for 5 min at 14000 r/min.
For electrophoresis mobility shift assays (EMSA) [27] , nuclear extracts were prepared by growing the cells to confluence, washing them 3 times in cold phosphate-buffered saline (PBS), and harvesting them by scraping. The cells were precipitated in a microcentrifuge, rinsed with hypotonic buffer (10 mmol/L HEPES (pH 7.9), 1.5 mmol/L MgCl 2 , and 10 mmol/L KCl), and resuspended in two pellet volumes of hypotonic buffer. After 5 min on ice, the suspension was lysed by adding 1 µL of 5% Nonidet P-40 and agitated by pipetting through a Pasteur pipette. Nuclei were then rocked for 30 min at 4 to ensure complete lysis with buffer C (20 mmol/L HEPES (pH 7.9), 20% glycerol, 100 mmol/L KCl, and 0.2 mmol/L EDTA). DTT (0.5 mmol/L), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 1 µg of leupeptin/mL, 1 µg of aprotinin/mL, 1 mmol/L sodium vanadate, and 20 mmol/L sodium fluoride were added to each solution just before use. [28] After protein quantification by the BCA Assay Reagent (Pierce Chemical, Inc.), 50 µg aliquots of protein lysates were mixed with the sample buffer and boiled for 5 min. The samples were then resolved on a 5% and 8% polyacrylamide gel containing SDS, and transferred to nitrocellulose membrane by electro blotting. The membrane was incubated in blocking buffer (TBS containing 5% skim milk and 0.1% Tween 20) for 2 h, followed by incubation with primary antibody diluted in the same buffer. Antibody was diluted to 1:1000. The membrane was washed in TBS containing 0.1% Tween 20. Specifically secondary antibody was detected using peroxidase-conjugated anti IgG at 1:10000. Relative proteins were detected by the supersignal chemiluminescence system (ECL, Pierce) followed by exposure to auto radiographic film. The nitrocellulose membrane was stripped with stripping buffer and reblotted. The antibodies were used as fol Immunoprecipitation for c-Jun and Jun B was done as follows. Five microliters of antibody and spepharose beads (Pharmacia) was mixed with 500 µg of total extract in 1 mL of lysis buffer plus protease and phosphatase inhibitors at 4 overnight. On the following day, beads were washed 4 times with lysis buffer plus inhibitors and boiled in SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer (50 mmol/L Tris.Cl (pH 6.8), 5% 2-mercaptoethanol, and 10% glycerol, 1% SDS) for loading onto a gel for 10% SDS-PAGE.
Immunoprecipitation and Western blot
Immunofluorescence analysis
Tet-on LMP1 HNE2 cells were treated with different concentrations of Dox for 24 h. After being washed with PBS, the cells were fixed in 4% paroformaldehyde. To identify c-Jun and Jun B protein, the cells were incubated first together with anti-c-Jun and Jun B IgG antibody, which was raised against a peptide mapping at the amino terminus of 1-79 site of c-Jun (sc-1694, Santa Cruz) and at the carboxyl terminus of the Jun B (sc-8051, Santa Cruz) respectively, and then reacted with the corresponding FITC and CY3-conjugated anti-IgG (Sigma) as the secondary antibody. Fluorescent images were observed and analyzed with a laser scanning confocal microscope (Bio-Rad MRC-1024ES).
Transient transfection and analysis
Transfections were performed using SuperFect transfection Reagent (Qiagen) method. Before the transfection, the cells were seeded in 6-well plates overnight, plasmid DNA (2.0 µg) and SuperFect transfection Reagent (10 µL). Each was diluted in serum-free medium (100 µL). DNA and SuperFect were then mixed and incubated for 10 min at room temperature to form transfection complexes. The cells were rinsed twice with PBS. We added 600 µL cell growth medium (containing serum and antibodies) to the transfection complexes, mixed and immediately transferred the whole volume to the cells. After 3 h of incubation at 37 in CO 2 incubator, the DNA-containing medium was replaced by fresh medium containing 10% serum and incubation of the cells continued for 36 h before use. The transfection cells were first used to extract total protein according to the previous material and methods. The plasmids used were as follows: JIP expression plasmid was kindly provided by Dr Davis [29] and β-galactosidase expression plasmid (pRSVβ-gal) was generously provided by Dr. Perkins [30] .
Electrophoresis mobility shift assay (EMSA)
For EMSA (LightShift TM Chemiluminescent EMSA Kit, No.20148, Pierce), 5 µg of nuclear extract was incubated with 2 nmol/L of the end-labeled with biotin double-stranded oligonucleotide 5′-TTCCGGC-TGACTCATCAAGCG-3′ biotin (The AP-1 site is shown in bold) [31, 32] in reaction buffer for 20 min at room temperature. For supershift reactions, the optimal concentration of each antibody was determined by titration into the EMSA reaction mixture. All antibodies (Jun B or c-Jun antibody) were added at the same concentration (12.5 ng/µL) to correspond to the optimal concentration of the least potent antibody that showed a discernible supershift. The samples were resolved on a nondenaturing 4% polyacrylamide-2% glycerol gel, and transferred to Biodyne® B Nylon membrane, avidin-HRP was used to show the shift. Transcription factor SP1 binding sequence was used as a control probe [32, 33] .
Results
Both c-Jun and Jun B were regulated by Epstein-Barr virus encoded latent membrane protein 1
To determine whether LMP1 could regulate the increase of c-Jun and Jun B protein, we used the LMP1 inducible expression cell line, Tet-on-LMP1 HNE2, as the cell model. We first tested the kinetics of LMP1 expression induced by 0.006, 0.06, 0.6, and 6.0 µg/mL of Dox respectively. LMP1 expression was increased after Dox addition in a dose-dependent manner (data not shown). Therefore, we selected 0.6 µg/mL Dox as the concentration for LMP1 induction in this study. Next, we studied the phosphorylation stages of JNK and c-Jun, in which LMP1 was induced by 0.6 µg/mL Dox from 0.5 to 24 h; after striping the membrane, we measured the changes of protein expression of c-Jun and Jun B at the same time.
The data in fig. 1 demonstrated that the amount of LMP1 protein increased with the extension of the induction time in Tet-on LMP1 HNE2 cells induced by Dox, and at the same time the phosphorylation of JNK increased rapidly and remained at a high level from 0.5 to 18 h, while both c-Jun and Jun B proteins sustained high levels from 0.5 to 4 h and then decreased gradually. The phosphorylation ser 63 site of c-Jun increased gradually during 0.5 and 2 h, reaching the peak and sustained at a high level at 4 h, while the phosphorylation ser 73 site of c-Jun also increased gradually during 0.5 and 4 h, reaching the peak at 4 h, and then decreased at 8 h point. The data presented here suggested that both phosphorylation and expression of JNK and Jun proteins were modulated by LMP1.
Formation of c-Jun/Jun Heterodimer mediated by EBV encoded LMP1
To examine whether heterodimer of c-Jun and Jun B occurred in response to LMP1, the immunofluorescent localization of c-Jun and Jun B was conducted using the corresponding c-Jun and Jun B specific antibody and observed with a laser-scanning confocal microscope. In this study, using cy3 labeled to Jun protein and FITC labeled to c-Jun, we found both fluorescence concentrated in the nucleus in Tet-on LMP1 HNE2 cells without doxycycline induction, but the two proteins did not overlap ( fig. 2) . However, the merged yellow fluorescence occurred 2, 4, 8, 12 and 24 h after the doxycycline induction. Meanwhile, the yellow signal also gradually decreased, which was similar to the changes of the protein expression modulated by LMP1 through Western blotting. The data demonstrated that there might be a heterodimer between c-Jun and Jun B triggered by LMP1.
Based on these findings, we further confirmed the colocalization relation between c-Jun and Jun B modulated by LMP1 via immunoprecipitation and Western blotting analysis. The nuclear proteins from Tet-on LMP1 HNE2 cells which were induced by Dox at different time were used an antibody of c-Jun to immunoprecipitate the nuclear protein and to analyze the Jun B expression with Western blotting. The data showed that Jun B began to increase at 2 h, peaked at 8 h, and then gradually decreased after the LMP1 proteins induced by Dox Tet-on-LMP1 HNE2 cells were treated with 0.6 µg/mL Dox at the indicated time ( fig.  3(a) ). Meanwhile, we used the antibody of Jun B to immunoprecipitate the nuclear protein and to analyze fig. 3(b) ), suggesting that c-Jun and Jun B may play their roles in a heterodimer form under LMP1 regulation.
Regulation of the Jun proteins occurs mainly through post-transcriptional modifications, such as phosphorylation. We further used the antibodies mapping against c-Jun, Phospho-c-Jun (Ser 63) and Phospho-c-Jun (Ser 73) to immunoprecipitate the nuclear proteins respectively, which were extracted from Tet-on LMP1 HNE2 cells induced by Dox for 12 h, and then analyzed the protein expression with Jun B antibody. The data did not demonstrate there were phosphorylation sites of c-Jun ser 63 and ser 73 in the c-Jun/Jun B dimmer ( fig. 4(a) ). However, we used To further confirm the relation between the levels of c-Jun phosphorylation (ser 63, ser 73) and the heterodimer formation of c-Jun/Jun B, we used JIP, which was a new anchor cytoplasmic protein and inhibited the functional activation of AP-1 [29] to block the c-Jun phosphorylation (ser 63, ser 73) through inhibiting the nuclear translocation of JNK. The data showed that the phosphorylation of c-Jun (ser 63, ser 73) decreased after the JIP transfection. The formation dimmer of We further identified whether the heterodimer of c-Jun and Jun B could bind to TRE sequences and change the DNA binding activity after the LMP1 protein induction. According to the TRE consensus sequence (TG AC/GT CA) [31, 32] , we designed the biotin labeled AP1 probes (5′-TTC CGG CTG ACT CAT CAA GCG-3′ biotin). Using nuclear extracts from Tet-on LMP1 HNE2 cells induced by 0.6 µg/mL Dox for 12 h and the described TRE sequence as a probe, the expected AP-1 DNA complex was observed ( fig.  5(a) ). The specificity of AP-1 DNA binding was supported by supershift of the protein-DNA complex by an excess of antibody c-Jun or Jun B. Meanwhile, the SP-1 DNA binding (5′-ATTCGATCGGGGCGGGG-CGAGC-3′ biotin) [32, 33] was supported for a revised experiment (data not shown).
The ability of c-Jun and Jun B binding to AP-1 D NA increased gradually at 0, 4, 12 h with Dox induction and then decreased gradually ( fig. 6(a) ), which was consistent with the IP-Western blotting ( fig. 3(a),  3(b) ).
Meanwhile the phosphorylation of c-Jun ser 63 and ser 73 increased the AP1 DNA binding activity ( fig. 5(b) ). When Tet-on LMP1 HNE2 cells were transfected with JIP-1, which inhibited the phosphorylation of c-Jun (ser 63, ser 73), both c-Jun and Jun B decreased the DNA binding activity to AP-1 consensus sequence ( fig.  5(c) ).
Discussion
Our previous studies have shown that LMP1 triggers a signaling cascade via its CTAR2 binding TRADD/TRAF2 signaling molecule, activates JNK and then up-regulates AP1 activity [22, 25, 30] . We also found that the carcinogenesis mechanism of LMP1 was much closely related to Jun B and c-Jun [23] . The N terminal of Jun B contains ubiquitin like anchoring sites domain, but lacks phosphoacceptor sites, so Jun B may interact with JNK [34, 35] , which implies Jun B may be involved in the process of a proteasome-dependent degradation by ubiquitination [36] . JNK-c-Jun association is ATP-independent and is required for efficient ATP-dependent phosphorylation of c-Jun at flanking phosphoacceptor sites (Ser 63 and Ser 73). The phosphorylation sites of c-Jun (ser 63, ser 73) play a vital role in the function of c-Jun [36, 37] , prevent it from proteasome-dependent degradation, and increase the stability. JNK plays an important role in the process of carcinogenesis [38] , and JNK is a serine/ threonine protein kinase regulated by phosphorylation and stimulated by ploy-L-lysine [39] , containing a dual role in the regulation of ubiquitination and phosphorylation on substrates [36] . Both c-Jun and Jun B are a substrate of JNK. Jun B is phosphorylated by JNK on Thr102 and Thr104 by competing with c-Jun for JNK binding and thus leading to reduced c-Jun phosphorylation, increasing both its own DNA binding and the transcription activation [8] .
The AP1 activity depends on both the abundance of different subgroups and the phosphorylation state. AP-1, an important transcription factor, plays its transcriptional role in a dimmer form. Both in different factor and at different time and places, AP-1 may form a new dimmer to regulate the gene transcription [40] . Thus, we speculated that LMP1 mediated the forma- tion of a new heterodimer of c-Jun and Jun B through the activation of JNK via the interaction with TRADD and TRAF [41] and phosphorylation of c-Jun and Jun B consequently [40] .
Our findings demonstrated that the expression of LMP1 increased in a time-dependent manner. However, the expression of c-Jun and Jun B decreased gradually; meanwhile, the level of JNK phosphorylation gradually increased, and so did the phosphorylation sites of c-Jun (ser 63, ser 73). Up to now, it is still short of Jun B antibody of which is specific in the phosphorylation site. However, we found there was a band shift of Jun B phosphorylation using Jun B antibody. The reason for this was the band disappeared after phosphorylatase treatment [40] , suggesting the Jun B regulated by LMP1 played an important role in the AP-1 signaling pathway. Thus, the regulation of c-Jun and Jun B was mainly at the posttranscription and phosphorylation level [41] . To further determine the interaction between Jun B and c-Jun induced by LMP1, we found that c-Jun colocalized with Jun B in the nucleus using laser confocal microscopy. Meanwhile, we found c-Jun formed a heterodimeric complex by LMP1 using IP-Western blotting and the c-Jun phosphorylation (Ser 63 and Ser 73) was closely related to the dimmer formation. The findings provided a new heterodimeric complex by LMP1 formed in the AP-1 family.
The important proof of the functional activation of AP-1 dimmer is the dimmer binding to the TRE consensus sequence of the target genes, which transactivates the transcription of the target genes. However, the previous studies suggested Jun B was a repressor of c-Jun, and could form a heterodimeric complex with c-Jun, which was inactive without DNA binding and transcription activities, resulting in the inhibition of the transcription activity of c-Jun and cell proliferation [18] . Many findings demonstrated that the phosphorylation of Jun protein did not change the DNA binding activity but increased the transcription activity [37, 42] . In this study, we found the c-Jun and Jun B heterodimeric complex by LMP1 increased the DNA binding activity. The phosphorylation level of c-Jun (ser 63, ser 73) was much closely related to the DNA binding activity of the heterodimeric complex. These findings provided a new mechanism of the interaction and function of transcription factor c-Jun and Jun B proteins, which increased the repertoire of possible regulatory complexes by LMP1 that may play an important role in the regulation of transcription of specific cellular genes in the process of genesis in nasopharyngeal carcinoma.
